Correlation of extended spectrum beta lactamases production with cephalosporin resistance in gram negative bacilli

Indian Journal of Pathology and Microbiology

Volumn 47, Issue 1, 2004, Pages 82-84

  Ghatole, Mangala ^a,b   Manthalkar, Pramod ^a   Kandle, Suresh ^a   Yemul, Vishwanath ^a   Jahagirdar, Vilas ^a  

^a Dr Vaishampayan Memorial Medical College   (India)

^b Basaweshwar Hospital   (India)

Author keywords

Extended spectrum beta lactamases production among gram negative bacilli

Indexed keywords

AMPICILLIN; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE; CEFALEXIN; CEFAZOLIN; CEFIXIME; CEFOXITIN; CEFTIZOXIME; CEFUROXIME; CEPHALOSPORIN DERIVATIVE; EXTENDED SPECTRUM BETA LACTAMASE; PENICILLIN DERIVATIVE; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; CITROBACTER; ENZYME SYNTHESIS; ESCHERICHIA COLI; GRAM NEGATIVE BACTERIUM; KLEBSIELLA AEROGENES; NONHUMAN; PROTEUS; PSEUDOMONAS; SALMONELLA TYPHI;

BETA-LACTAMASES; CEPHALOSPORIN RESISTANCE; ENTEROBACTERIACEAE; GRAM-NEGATIVE BACTERIA; HUMANS;

EID: 4444378297     PISSN: 03774929     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Livermore DM. Mechanism of resistance to beta lactam antibiotics. Scand J Infect Dis 1991; 78(suppl):7.
2. Phillipon AR, Labia R, Jacoby G. Extended spectrum beta lactamases. Antimicrob Agents Chemother 1989; 33:1131-6.
3. Sanders CC. Beta lactamases of Gram negative bacteria: new challenges for new drugs. Clin Infect Dis 1992; 14:1089-99.
4. Jarliver V, Nicolas MH, Fournier G, Phillipon A. Extended broad spectrum beta lactamases conferring transferable resistance to newer Beta lactam agents in Enterobaceriaceae-hospital prevalence and susceptibility patterns. Rev Infect Dis 1988; 10:867-78.
5. Ehrhardt AF, Sanders CC. Beta lactamase resistance among Enterobacter species. J Antimicrob Chemother 1993; 32(supplB):1-11.
6. Nadal D, Von Gravenenitz A. Routine detection of inducible beta lactamase in Gram negative bacilli by means of disc susceptibility testing. J Microbiol Methods 1993; 17:283-91.
7. Casellas JM, Goldberg M. Incidence of strains producing extended spectrum beta lactamases in Argentina. Infection 1989; 17:434-6.
8. Chaudhary A, Rao TV. Bacteriaemia in a tertiary care urban hospital in India. Indian J Pathol Microbiol 1999; 42(3):317-20.
9. Soneja S, Jindal N, Mohal U. Susceptibility pattern of common clinical isolates to Cefoperazone- a newer third generation cephalosporin. Indian J Med Microbiol 1997; 15(3):143-6.
10. Champs CDE, Sauvant MP, Chandal C et al. Prospective survey of colonization and infection caused by expanded spectrum beta lactamase producing members of the family-Enterobacteriaceae in an intensive care unit. J Clin Microbiol 1989; 27(12):2887-90.
11. Revathi G, Singh S. Detection of expanded spectrum cephalosporin resistance due to inducible lactamases in hospital isolates. Indian J Med Microbiol 1997; 5(3):113-5.
12. Ananthakrishnan AN, Kanungo R, Kumar A, Badrinath S. Detection of extended spectrum beta lactamase producers among surgical wound infections and bums patients in JIPMER. Indian J Med Microbiol 2000; 18(4):160-5.
13. Buisson CB, Legrand P, Phillipton A, Montravers F, Anquer M, Duval J. Transferable enzymatic resistance to third generation cephalosporin during nosocomial outbreak of multiresistant Klebsiella pneumoniae. Lancet 1987; 8:302-6.